
Aker BioMarine Investor Relations Material
Latest events

Q2 2025
Aker BioMarine
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aker BioMarine
Access all reports
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications. Aker BioMarine AS operates through Fish Oils and Pelagic Protein segments. Its products include astaxanthin; fish oil; EPA; acetyl-L-carnitine (ALCAR); omega-3 phospholipids; and omega-3 fatty acids. It also offers products that contain its products that contain astaxanthin in skin care preparations. Aker BioMarine AS markets its products under the AkerBioSolutions brand to food companies and manufacturers of dietary supplements, as well as to producers of livestock feed for hens and pigs.
Key slides for Aker BioMarine


Q2 2025
Aker BioMarine


Q4 2024
Aker BioMarine
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AKBM
Country
🇳🇴 Norway